Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 21st October 2020 from 07:00 AM to 07:00 PM (BST).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 83, 2015
Previous Article Next Article

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Author affiliations

Abstract

A series of novel chalcone analogues were designed, synthesized and evaluated as anticancer agents. The results of antiproliferative activity tests showed that most of the analogues exhibited moderate to very good antiproliferative activities with GI50 values in the micromol to sub-micromol range. Especially compound 10a gave 0.026 μM to 0.035 μM GI50 for five cancer cell lines. The mechanistic studies including tubulin polymerization inhibition, disruption of microtubule dynamics and cell cycle arrest assay demonstrated that compound 10a could effectively inhibit in vitro cellular tubulin polymerization, interfere with the mitosis, resulting in a prolonged G2/M cell cycle arrest and ultimately lead to cell apoptosis of cancer cells. Taken together, these results suggested that 10a may became a promising lead compound for development of new anticancer drugs.

Graphical abstract: Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Back to tab navigation

Supplementary files

Article information


Submitted
27 Jul 2015
Accepted
03 Aug 2015
First published
03 Aug 2015

RSC Adv., 2015,5, 68128-68135
Article type
Paper

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

J. Chen, J. Yan, J. Hu, Y. Pang, L. Huang and X. Li, RSC Adv., 2015, 5, 68128
DOI: 10.1039/C5RA14888J

Social activity

Search articles by author

Spotlight

Advertisements